Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 25;15(1):43. doi: 10.5334/gh.830

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2020 The Author(s)

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Cost-effectiveness of statin treatment among people with different risk of ASCVD. Data are incremental cost-effectiveness ratios (Int$ per QALY gained).

ASCVD, atherosclerotic cardiovascular disease; ICER, incremental cost-effectiveness ratio.

In healthcare sector perspective direct cost such as change of ASCVD treatment cost due to decrease of ASCVD incidence, statin medicine cost, statin treatment related cost, routine healthcare cost, and adverse events treatment cost were included.

In societal perspective both direct and indirect costs were included. The indirect cost included patient-time costs, unpaid caregiver-time, transportation costs, and labor market earnings lost.